3.0.0 440 2022-11-01T16:02:58Z 2022-11-01T16:02:58Z Senate S 2019-02-12 116 ssju00 Judiciary Committee Senate Standing Reported by 2019-06-28T17:27:23Z Markup by 2019-06-27T14:00:40Z Referred to 2019-02-12T16:01:13Z 2019-06-28 Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 129. Calendars 2019-06-28 ssju00 Judiciary Committee Senate Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report. Committee 2019-06-28 Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report. Committee 14000 9 Library of Congress ssju00 Judiciary Committee 2019-06-27 ssju00 Judiciary Committee Senate Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. Committee 2019-02-12 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2019-02-12 Introduced in Senate IntroReferral 10000 9 Library of Congress C001095 Sen. Cotton, Tom [R-AR] Tom Cotton R AR N E000295 Sen. Ernst, Joni [R-IA] Joni Ernst R IA 2019-02-12 True T000461 Sen. Toomey, Patrick [R-PA] Patrick Toomey R PA J. 2019-02-12 True 2019-07-19T16:36:57Z S. 440, PACED Act https://www.cbo.gov/publication/55467 As reported by the Senate Committee on the Judiciary on June 28, 2019 Commerce Civil actions and liability Competitiveness, trade promotion, trade deficits Federal-Indian relations Government liability Intellectual property Jurisdiction and venue Sovereignty, recognition, national governance and status Commerce 00 2019-02-12 Introduced in Senate 2019-09-05T19:24:42Z Preserving Access to Cost Effective Drugs Act or the PACED Act

This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.

Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.

]]> 25 2019-06-28 Reported to Senate 2020-09-29T20:06:18Z Preserving Access to Cost Effective Drugs Act or the PACED Act

This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.

Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court. The abrogation of sovereign immunity shall not apply to states or institutions of higher education (i.e., public state universities and institutions).

]]> PACED Act Display Title PACED Act Short Title(s) as Introduced PACED Act Introduced in Senate IS Short Title(s) as Introduced Preserving Access to Cost Effective Drugs Act Introduced in Senate IS Short Title(s) as Reported to Senate PACED Act S Senate Reported to Senate RS Short Title(s) as Reported to Senate Preserving Access to Cost Effective Drugs Act S Senate Reported to Senate RS Official Title as Introduced A bill to amend title 35, United States Code, to provide that a patent owner may not assert sovereign immunity as a defense in certain actions before the United States Patent and Trademark Office, and for other purposes. Introduced in Senate IS Reported to Senate 2019-06-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s440rs/xml/BILLS-116s440rs.xml Introduced in Senate 2019-02-12T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s440is/xml/BILLS-116s440is.xml 2019-06-28 Placed on Senate Legislative Calendar under General Orders. Calendar No. 129. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.